Best Practices



Recently approved therapies, drugs in development, and expanded labels for existing psoriasis drugs continue to offer clinicians and patients an expanding range of options for treatments.


This article focuses on the baseline risk of malignancy, risks associated with treatments for psoriasis, and management strategies for patients with psoriasis and a history of malignancy.

Case Reports

This case evaluates follicular psoriasis, an uncommon variant manifesting as scaly folliculocentric hyperkeratotic eruptions of the trunk and extremities.